Feb 29 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Okta, Salesforce and Sarepta Therapeutics, on Thursday.
HIGHLIGHTS
* Clearwater Analytics Holdings Inc : JP Morgan cuts to neutral from
overweight
* Okta Inc : Piper Sandler raises target price to $110 from $85
* Salesforce Inc : Barclays raises target price to $355 from $325
* Sarepta Therapeutics Inc : Leerink Partners raises target price to $165
from $145
* Universal Health Services Inc : Leerink Partners raises target to $192 from
$174
Following is a summary of research actions on U.S. companies reported by Reuters on Thursday. Stock entries are in alphabetical order.
* Acadia Healthcare Company Inc : Leerink Partners raises target to $100 from $95
* Advance Auto Parts Inc : JP Morgan raises target price to $68 from $55
* Alkami Technology Inc : JP Morgan raises target price to $31 from $27
* Array Technologies Inc : Scotiabank cuts target price to $25 from $33
* Atea Pharmaceuticals Inc : Leerink Partners raises target price to $5 from $4
* Avidxchange Holdings Inc : Piper Sandler raises target price to $14 from $13
* Avidxchange Holdings Inc : Susquehanna raises target price to $16 from $15
* Clearwater Analytics Holdings Inc : JP Morgan cuts target price to $22 from $24
* Clearwater Analytics Holdings Inc : JP Morgan cuts to neutral from overweight
* Crowdstrike Holdings Inc : JP Morgan raises target price to $350 from $300
* Dine Brands Global Inc : Wedbush raises target price to $48 from $46
* Editas Medicine Inc : Leerink Partners raises target price to $10 from $9
* Gulfport Energy Corp : Truist Securities raises target price to $184 from $170
* Inari Medical Inc : BTIG cuts target price to $86 from $93
* Inari Medical Inc : Truist Securities cuts target price to $61 from $63
* Marvell Technology Inc : Oppenheimer raises target price to $80 from $70
* Mersana Therapeutics Inc : Truist Securities raises to buy from hold
* Monster Beverage Corp : Jefferies raises target price to $69 from $66
* Nutanix Inc : JP Morgan raises target price to $70 from $65
* Nutanix Inc : Piper Sandler raises target price to $76 from $67
* Okta Inc : BTIG raises target price to $124 from $100
* Okta Inc : Piper Sandler raises target price to $110 from $85
* Permian Resources Corp : Susquehanna raises target price to $16 from $15
* Revance Therapeutics Inc : Piper Sandler cuts target price to $20 from $42
* Rxsight Inc : JP Morgan raises target price to $62 from $40
* Salesforce Inc : Barclays raises target price to $355 from $325
* Salesforce Inc : Raymond James raises target price to $380 from $300
* Sarepta Therapeutics Inc : Leerink Partners raises target price to $165 from $145
* Schrodinger Inc : Piper Sandler cuts target price to $50 from $60
* Shoals Technologies Group Inc : Piper Sandler cuts target price to $16 from $20
* Silk Road Medical Inc : JP Morgan raises target price to $19 from $10
* Slr Investment Corp : JP Morgan cuts target price to $15 from $15.5
* Snowflake Inc. : D.A. Davidson cuts target price to $230 from $260
* Snowflake Inc. : Melius Research cuts target price to $185 from $202
* Snowflake Inc. : Scotiabank cuts target price to $207 from $226
* Steven Madden Ltd : Wedbush raises target price to $41 from $38
* United Parks & Resorts Inc : JP Morgan raises target price to $61 from $57
* Universal Health Services Inc : Leerink Partners raises target to $192 from $174
* Vacasa Inc : JP Morgan raises target price to $10 from $8
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
Comments